NAT2 rs1495741 and anti-tuberculosis drug-induced liver injury in children: genetic association and risk prediction
Xin Huang, Jie Jiang, Li He, Yan Guo, Jianzhu Zhou, Hui Qiu, Haiyi Zhou, Xiaoyan Liu, Hanjie Yang, Chengxian Guo · 2026
Read NAT2 rs1495741 and anti-tuberculosis drug-induced liver injury in children: genetic association and risk prediction by Xin Huang, Jie Jiang, Li He, Yan Guo, Jianzhu Zhou, Hui Qiu, Haiyi Zhou, Xiaoyan Liu, Hanjie Yang, Chengxian Guo (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13195251.txt.
Description
Xin Huang and co-authors published a research paper in 2026 on a gene variant that predicts liver injury in children treated for tuberculosis. The cure's drugs can harm the liver, and children who clear one drug slowly face the most risk. The team studied 192 treated children, thirty-one of whom suffered liver injury.
One variant in a gene that processes the drug stood out after strict checks. Children with two copies of the risky form had over seven times the risk of injury. That form matched the slow-clearing type closely and went with higher drug levels in blood. A test for it could warn doctors before treatment starts.
Catalog record
| CREATOR | Xin Huang, Jie Jiang, Li He, Yan Guo, Jianzhu Zhou, Hui Qiu, Haiyi Zhou, Xiaoyan Liu, Hanjie Yang, Chengxian Guo |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 38 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |